Health in Germany 1,089 indicators covering health for Germany. IndicatorLatest Year10-yr change Rank Sales of beer in 1000s hectolitres 87.89 2009 down 14.9% 60th Confirmed cases of MDR-TB 64 2012 down 39.0% 50th Self-perceived health by sex, age and educational attainment level 46.7 2025 down 2.1% 25th People having a long-standing illness or health problem, by sex, age 14 2025 down 26.3% 15th Healthy life years by sex 81.2 2024 unchanged 21st New cases: other 10 2012 — 22nd Health care expenditure by function 569,221 2025 up 68.9% 1st Health care expenditure by financing scheme 569,221 2025 up 68.9% 1st Expenditure for selected health care functions by health care 569,221 2025 up 68.9% 1st Health care expenditure by provider 569,221 2025 up 68.9% 1st Expenditure for selected health care providers by health care 569,221 2025 up 68.9% 1st Expenditure for selected health care functions by health care 528,491 2024 up 64.4% 1st Persons having a longstanding health problem by level of disability 14 2025 down 25.1% 13th Self-perceived health by level of disability (activity limitation) 88.5 2025 down 2.7% 28th Healthy life expectancy based on self-perceived health 74 2024 down 2.1% 21st Infant mortality by age and sex 874 2024 up 5.2% 4th Number of imported cases of cutaneous leishmaniasis reported 12 2023 up 20.0% 13th Health impacts of air pollution 216,546 2023 down 64.6% 3rd Primary health care expenditure (PHCE) per сapita in US$ 2,846 2023 up 38.9% 5th Revenues of health care financing schemes 528,491 2024 up 64.4% 1st Revenues of health care financing schemes by health care financing 528,491 2024 up 64.4% 1st Deaths related to infectious diseases 10,556 2023 down 0.7% 1st Causes of death - infant mortality by country of occurrence 2,210 2023 up 43.6% 5th Fetal, peri- and neonatal mortality rates by country of occurrence 0 2023 down 100.0% 34th Peri-neonatal mortality by age of mother, country of residence and 0 2023 down 100.0% 34th Proportion of bloodstream infection due to Escherichia coli resistant 9.8% 2023 down 15.5% 53rd Reported cases of syphilis 9,123 2023 up 71.3% 4th Causes of death - potential years of life lost by treatable and 3,016 2023 down 10.1% 15th People having a long-standing illness or health problem, by sex, age 23.7 2025 down 28.4% 15th Treatable and preventable mortality of residents by cause and sex 199,161 2023 up 0.9% 2nd Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicr 24.5 2022 up 1,196.3% 11th Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicr 200 2022 up 88.7% 20th Proportion of bloodstream infection due to methicillin-resistant Staph 5.3% 2023 down 48.3% 46th Causes of death - infant mortality by country of residence 2,211 2023 up 43.4% 4th Influenza vaccination rate elderly oecd 47.3 2020 down 15.7% 24th Excess mortality by month -6.4 2026 down 120.6% 19th Breast cancer screening coverage in europe 51.6 2022 down 8.3% 16th Total use of antibacterials expressed as DDD per 1000 inhabitants per 13.48 2023 up 4.9% 37th Pattern of antibiotic consumption at national level 60.96 2023 up 16.1% 31st Hospital days of in-patients - historical data 158.72 million 2021 down 14.3% 1st Hospital discharges by diagnosis, in-patients, total number 18.13 million 2021 down 8.8% 1st Hospital discharges by diagnosis, in-patients, per 100 000 21,790 2021 down 10.3% 3rd Infant mortality by mother's educational attainment level (ISCED11f) 2,245 2024 — 3rd Imports in 1000s hectolitres 5.6 2007 up 56.8% 117th Hospital discharges by diagnosis, day cases, total number 417,605 2021 down 23.0% 11th Number of isolates tested for ceftriaxone 200 2020 up 83.5% 15th Proportion of isolates with decreased susceptibility or resistance (DS 0 2020 — 13th Hospital discharges by diagnosis, day cases, per 100 000 inhabitants 502 2021 down 24.3% 21st Proportion of isolates with resistance to azithromycin reported to WHO 16 2020 up 93.8% 8th Number of isolates tested for azithromycin 200 2020 up 83.5% 16th Proportion of isolates with resistance to ciprofloxacin reported to WH 61.2 2018 down 16.5% 23rd Number of isolates tested for ciprofloxacin 201 2018 up 346.7% 17th Proportion of isolates with decreased susceptibility or resistance (DS 1 2018 down 55.0% 18th Number of isolates tested for extended-spectrum cephalosporins 201 2018 up 346.7% 14th Proportion of children at the end of lower secondary achieving at leas 82.8% 2015 up 3.3% 15th Exports of beer (barley) in 1000s hectolitres 13.51 2009 up 23.4% 64th Proportion of isolates with decreased susceptibility or resistance (DS 1 2018 down 55.0% 12th Number of isolates tested for cefixime 201 2018 up 346.7% 6th Alcohol-related road traffic crashes with fatalities 9.4% 2012 down 22.3% 23rd Alcohol-related road traffic crashes with fatalities 9.4% 2012 down 22.3% 23rd ← Previous Page 18 of 19 Next →